Briviact and Status epilepticus - a phase IV clinical study of FDA data

Summary:

Status epilepticus is reported as a side effect among people who take Briviact (brivaracetam), especially for people who are male, 2-9 old, have been taking the drug for 1 - 6 months also take Eliquis, and have Seizures.

The phase IV clinical study analyzes which people have Status epilepticus when taking Briviact. It is created by eHealthMe based on reports of 3,408 people who have side effects when taking Briviact from the FDA, and is updated regularly.

What is Briviact?

Briviact has active ingredients of brivaracetam. It is often used in epilepsy. eHealthMe is studying from 3,433 Briviact users. Check the latest studies of Briviact.

What is Status epilepticus?

Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure) is found to be associated with 662 drugs and 949 conditions by eHealthMe. Check the latest studies of Status epilepticus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

3,408 people reported to have side effects when taking Briviact.
Among them, 65 people (1.91%) have Status epilepticus.

Could Briviact cause Status epilepticus?

Among these 65 people:

How long have people been on Briviact when they have Status epilepticus? *

What is the gender of people who have Status epilepticus when taking Briviact? *

female: 31.67 %
male: 68.33 %

What is the age of people who have Status epilepticus when taking Briviact? *

What are other drugs people take besides Briviact? *

What are other side effects people have besides Status epilepticus? *

Drug Level Fluctuating: 19 people, 29.23%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 18 people, 27.69%
Depression: 8 people, 12.31%
Drug Ineffective: 6 people, 9.23%
Multiple-Drug Resistance: 5 people, 7.69%
Abnormal Behavior: 4 people, 6.15%
Gingival Pain (gum pain): 4 people, 6.15%
Partial Seizures (seizures which affect only a part of the brain at onset): 4 people, 6.15%
Drowsiness: 3 people, 4.62%
Memory Loss: 3 people, 4.62%

What are the existing conditions these people have? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 16 people, 24.62%
Partial Seizures (seizures which affect only a part of the brain at onset): 6 people, 9.23%
Holt-Oram Syndrome (skeletal abnormalities of the hands and arms (upper limbs) and heart problems): 1 person, 1.54%
Dysmenorrhea (painful menstruation): 1 person, 1.54%

* Approximation only. Some reports may have incomplete information.

Do you take Briviact and have Status epilepticus?

- Check whether Status epilepticus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Briviact:

Briviact (3,433 reports)

Browse all side effects of Briviact:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Status epilepticus:

Status epilepticus (662 drugs)

Browse all the conditions that are associated with Status epilepticus:

Status epilepticus (949 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on brivaracetam (the active ingredients of Briviact) and Briviact (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.